Navigation Links
AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance
Date:5/14/2013

BOSTON, May 14, 2013 /PRNewswire/ -- On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a changing clinical trial research landscape.

Among the clinical trial leaders in attendance will be AG Mednet CEO Abraham Gutman who will moderate a special program about successful site leadership and disruptive technologies transforming investigator sites and challenging old assumptions among global networks.

Gutman, recently recognized by CenterWatch as one of 20 innovators changing the face of the clinical trial industry, is responsible for leading AG Mednet and its breakthrough technology that improves the quality of clinical trials by eliminating preventable and costly human errors.

For more information about AG Mednet or to schedule a conversation with Abraham Gutman about the role of disruptive technologies at clinical trial investigative sites around the world, please email agmednet@hbagency.com.

For more information about the Inaugural Forum on Optimizing Clinical Research Performance, please visit http://www.iibig.com/conferences/P1301/overview.html.

About AG Mednet

AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, AG Mednet is the leading

SOURCE AG Mednet
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
2. AG Mednet and Japans Biovisiq Bring Zero-Delay Clinical Trial Solutions to Asian Pharmaceutical Market
3. MedNet Solutions To Participate In Multiple Clinical Research Conferences In April 2013
4. AG Mednet Announces Cloud Storage Solution with On-Demand Access to Clinical Trial Data
5. MedNet Solutions To Sponsor And Participate In The 2012 SCDM Annual Conference
6. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
7. Prairie Education & Research Cooperative Joins MedNet Solutions iMedNet CRO Partner Program
8. MedNet Solutions to Unveil Innovative New iMedNet EDC Features at The 48th DIA Annual Meeting
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... SYDNEY and SOUTHAMPTON , ... -- Australian pharmaceutical company Pharmaxis Ltd (ASX: PXS) and UK biotechnology ... into a research collaboration to develop a selective inhibitor to ... fatal lung disease idiopathic pulmonary fibrosis (IPF). ... US. Current products are expected to produce global revenues in ...
(Date:8/4/2015)... VIEW, Calif. , Aug. 4, 2015  IRIDEX ... James H. Mackaness , who had served as chief ... since 2012, has resigned his positions with the Company, ... officer position at another company. Mr. Mackaness intends to ... Company,s second quarter earnings announcement and 10-Q filing. ...
(Date:8/4/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today ... ended June 30, 2015 and provided a summary ... second quarter of 2015 and recent period marked ... Paul Grint, M.D., President and CEO of Regulus. ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 2Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 3Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 4Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 5Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 6Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 7Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 8Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 9Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 10
... Reaffirms Primacy and Safety of ,First Generation, Antisense, ... (Nasdaq: GNTA ) announced the presentation of ... lead anticancer,compound, can be safely administered in high ... data were presented by Dr. Anthony Tolcher, Director,of ...
... - Studies Show Improvement in Hemodynamics and Delay ... Actelion Pharmaceuticals US, Inc.,today announced positive results from ... and effective as a combination therapy,for the treatment ... suggest that Tracleer, when given in combination with ...
Cached Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
(Date:8/5/2015)... Baltimore (PRWEB) , ... August 05, 2015 , ... ... Nivel Siete, Remote-Learner and Blackboard’s open source companies (Moodlerooms, NetSpot and Remote-Learner UK) ... to formulate common standards and guidelines that will improve and streamline the process ...
(Date:8/5/2015)... ... , ... Jvion’s CEO, Shantanu Nigam , was named Readers’ choice: 21 ... designation is given to those leaders who are enabling innovation within healthcare IT. Shantanu ... firm’s clinical predictive analytic solutions. , A spokesperson for Jvion said, “Since our inception, ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... of $5.1 Billion by 2020, signifying a firm annualized growth of 11.7% between ... experiencing a steady growth due to increasing demand of ceramic membranes technologies and ...
(Date:8/5/2015)... ... , ... The June 6 opening of Chicago’s new elevated trail, the 606, has been getting ... a group of walkers at Sedgebrook senior living community in Lincolnshire. Known as the ... preserves and twice per month to more distant places. When they read about the ...
(Date:8/5/2015)... ... ... What language does a body speak? "Body Language – from Head to Toe" ... contain the name of a body part. , The use of body part-related expressions ... and expressions, for example, “back against the wall,” “brainstorming,” “sweet tooth,” and “tongue in ...
Breaking Medicine News(10 mins):Health News:Moodle Service Providers to Simplify Moodle Plugin Development 2Health News:Moodle Service Providers to Simplify Moodle Plugin Development 3Health News:Moodle Service Providers to Simplify Moodle Plugin Development 4Health News:Jvion’s Shantanu Nigam Named One of the 21 Health IT Leaders to Know 2Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 2Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 3Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 4Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 5Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Harvard Medical Professor Dr. Per-Olof Hasselgren Pens Unique Book Using Body Part Idioms 2
... Chico,s (NYSE: CHS ) is thrilled to ... the American Heart Association,s mission to prevent cardiovascular disease ... 2009, Chico,s committed to donate $2.82 from each sale ... Heart Association (AHA) in support of its Start! Movement, ...
... Month and groups across the country and around the globe ... awareness period. The purpose of Men,s Health Month is ... early detection and treatment of disease among men and boys. ... 15-21, the week ending on Father,s Day, a special awareness ...
... been babies, adults have crooned lullabies to soothe them. But ... suckle better and reduce their pain. , If confirmed, this ... babies feed on their own faster and move them out ... clinical professor in the Faculty of Medicine & Dentistry,s Department ...
... study is the first to show that there is ... disease in the general U.S. adult population. This work ... in highly-exposed chemical workers. The study is being presented ... ), the largest international gathering of physicians and researchers ...
... Orthodox Jewish School in Northeast Philadelphia , ... Philadelphia, ... largest medical assistance managed care organization in Pennsylvania, will hold a ... a new, safe playground at Politz Hebrew Academy, an Orthodox Jewish ...
... Advance Health Care Investment OpportunitiesCHICAGO, May 29 ... private equity firm focused exclusively on the health care ... to join the firm as a partner, effective July ... Mr. Womsley, 45, will work with Water Street,s team ...
Cached Medicine News:Health News:Chico's Raises $200K for the American Heart Association 2Health News:Join Men's Health Network in Celebration of Men's Health Month 2Health News:Join Men's Health Network in Celebration of Men's Health Month 3Health News:Music may improve feeding, reduce pain in premature babies: U of A study 2Health News:Environmental pollution increases the risk of liver disease 2Health News:Groundbreaking for Safe Playground Build at Politz Hebrew Academy 2Health News:Citi Private Equity Executive Joins Water Street Healthcare Partners 2Health News:Citi Private Equity Executive Joins Water Street Healthcare Partners 3
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass....
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
Medicine Products: